214607 School of Public and Community Health Sciences, University of Montana, Missoula, MT, USA.
214607 School of Social Work, University of Montana, Missoula, MT, USA.
Public Health Rep. 2020 Nov/Dec;135(6):842-850. doi: 10.1177/0033354920954512. Epub 2020 Sep 24.
Human papillomavirus (HPV) vaccination rates among adolescents are lower in rural areas than in urban areas of the United States. The objective of this study was to identify barriers to and facilitators of adolescent HPV vaccination in Montana, a large, primarily rural state.
Using a mixed-methods design, we integrated quantitative analyses of Montana's National Immunization Survey-Teen (NIS-Teen) data from 2013-2017 with qualitative data collected at a statewide meeting in October 2018 and from stakeholder interviews conducted from October 2018 through June 2019. Using NIS-Teen data, we identified trends and estimated adjusted prevalence ratios (aPRs) to identify factors associated with vaccine uptake. Using directed content analysis of qualitative data, we identified themes related to vaccine uptake.
In Montana, initiation of the HPV vaccine series among adolescents aged 13-17 increased from 34.4% in 2013 to 65.5% in 2017. We identified 6 themes related to HPV vaccination from qualitative analyses, including medical providers' recommendation style as a facilitator of vaccination and parental vaccine hesitancy as a barrier to vaccination. In NIS-Teen 2017 data (n = 326 adolescents), receiving a medical provider recommendation was significantly associated with series initiation (aPR = 2.3; 95% CI, 1.5-3.6). Among parents who did not intend to initiate the vaccine series for their adolescent within 12 months (n = 71), vaccine safety was the top concern (aPR = 24.5%; 95% CI, 12.1%-36.9%).
HPV vaccination rates have increased in Montana but remain lower than rates for other adolescent vaccines. Future work should focus on reducing missed opportunities, increasing parents' knowledge of and confidence in vaccination, and training medical providers on addressing common vaccine concerns.
美国农村地区青少年人乳头瘤病毒(HPV)疫苗接种率低于城市地区。本研究旨在确定蒙大拿州青少年 HPV 疫苗接种的障碍和促进因素,蒙大拿州是一个以农村为主的大州。
采用混合方法设计,我们整合了蒙大拿州 2013-2017 年国家免疫调查-青少年(NIS-Teen)数据的定量分析,以及 2018 年 10 月全州会议收集的定性数据和 2018 年 10 月至 2019 年 6 月进行的利益相关者访谈的定性数据。使用 NIS-Teen 数据,我们确定了趋势并估计了调整后的流行率比(aPR),以确定与疫苗接种率相关的因素。使用定性数据的有针对性的内容分析,我们确定了与疫苗接种相关的主题。
在蒙大拿州,13-17 岁青少年 HPV 疫苗系列接种率从 2013 年的 34.4%上升到 2017 年的 65.5%。我们从定性分析中确定了与 HPV 疫苗接种相关的 6 个主题,包括医疗服务提供者推荐风格作为接种的促进因素和父母对疫苗的犹豫作为接种的障碍。在 2017 年 NIS-Teen 数据(n=326 名青少年)中,收到医疗服务提供者的推荐与系列接种的启动显著相关(aPR=2.3;95%CI,1.5-3.6)。在 12 个月内不打算为青少年启动疫苗系列的父母中(n=71),疫苗安全性是最关注的问题(aPR=24.5%;95%CI,12.1%-36.9%)。
蒙大拿州 HPV 疫苗接种率有所上升,但仍低于其他青少年疫苗接种率。未来的工作应重点减少错失机会,提高父母对疫苗接种的了解和信心,并培训医疗服务提供者解决常见的疫苗问题。